Avadel Pharmaceuticals PLC (AVDL)
18.59
-0.23
(-1.22%)
USD |
NASDAQ |
May 06, 16:00
18.60
+0.02
(+0.08%)
After-Hours: 20:00
Avadel Pharmaceuticals Gross Profit Margin (Quarterly): 96.44% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 96.44% |
| September 30, 2023 | 98.33% |
| June 30, 2023 | 97.59% |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | 67.45% |
| March 31, 2020 | 79.93% |
| December 31, 2019 | 78.04% |
| September 30, 2019 | 80.16% |
| June 30, 2019 | 79.37% |
| March 31, 2019 | 80.13% |
| December 31, 2018 | 79.48% |
| September 30, 2018 | 84.26% |
| June 30, 2018 | 87.98% |
| March 31, 2018 | 80.20% |
| December 31, 2017 | 88.35% |
| Date | Value |
|---|---|
| September 30, 2017 | 90.45% |
| June 30, 2017 | 90.15% |
| March 31, 2017 | 92.57% |
| December 31, 2016 | 93.99% |
| September 30, 2016 | 91.14% |
| June 30, 2016 | 89.95% |
| March 31, 2016 | 89.21% |
| December 31, 2015 | 93.41% |
| September 30, 2015 | 95.59% |
| June 30, 2015 | 94.33% |
| March 31, 2015 | 88.91% |
| December 31, 2014 | 77.25% |
| September 30, 2014 | 72.78% |
| June 30, 2014 | 88.26% |
| March 31, 2014 | 83.11% |
| December 31, 2013 | 71.44% |
| September 30, 2013 | 68.91% |
| June 30, 2013 | 76.85% |
| March 31, 2013 | 80.64% |
| December 31, 2012 | 64.78% |
| September 30, 2012 | 72.21% |
| June 30, 2012 | 74.36% |
| March 31, 2012 | 82.09% |
| December 31, 2011 | 78.61% |
| September 30, 2011 | 89.18% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
67.45%
Minimum
Jun 2020
98.33%
Maximum
Sep 2023
84.66%
Average
80.05%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Trinity Biotech PLC | 34.01% |
| Medtronic PLC | 65.61% |
| Akari Therapeutics PLC | -- |
| Biophytis SA | -- |
| TC BioPharm (Holdings) PLC | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -284.4% |
| Return on Assets | -95.14% |
| Return on Invested Capital | -141.4% |
| Profit Margin (Quarterly) | -148.0% |
| Operating Margin (Quarterly) | -128.0% |
| Return on Net Operating Assets | -370.3% |